Next Article in Journal
Overview of Self-Management Skills and Associated Assessment Tools for Children with Inflammatory Bowel Disease
Next Article in Special Issue
New Tools for Precision and Personalized Treatment in Gastrointestinal Cancers
Previous Article in Journal
Median Arcuate Ligament Syndrome Clinical Presentation, Pathophysiology, and Management: Description of Four Cases
Previous Article in Special Issue
Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine

Clinical Impact of Sarcopenia on Gastrointestinal Tumors

Surgery Resident, Braga Hospital, 4710-243 Braga, Portugal
Coloproctology Unit, Surgery Department, Braga Hospital, 4710-243 Braga, Portugal
School of Medicine, University of Minho, 4710-070 Braga, Portugal
PT Government Associate Laboratory, Life and Health Sciences Research Institute (ICVS)/3B’s, 4710-070 Braga/Guimarães, Portugal
Author to whom correspondence should be addressed.
Gastrointest. Disord. 2021, 3(1), 51-60;
Received: 21 January 2021 / Revised: 26 February 2021 / Accepted: 26 February 2021 / Published: 23 March 2021
Preoperative risk stratification in cancer surgery is important to improve treatment and outcome. Sarcopenia is defined by progressive and generalized loss of skeletal muscle mass and strength and is now getting attention as a poor prognostic factor. The purpose of this review was to explore the impact of sarcopenia on short and long-term outcomes in patients undergoing surgical resection of gastrointestinal tumors. Recent studies suggest that sarcopenia contributes to postoperative complications and overall survival. The relatively simple evaluability, as well as its modifiable nature, provides an intriguing potential for sarcopenia to be included in standard preoperative clinical evaluation. Such evaluations can provide physicians with important information to target high-risk individuals with prophylactic measures and eventually improve surgical outcomes. View Full-Text
Keywords: gastrointestinal tumors; morbimortality; sarcopenia gastrointestinal tumors; morbimortality; sarcopenia
MDPI and ACS Style

Pereira, A.; Pereira, J.C.; Martins, S.F. Clinical Impact of Sarcopenia on Gastrointestinal Tumors. Gastrointest. Disord. 2021, 3, 51-60.

AMA Style

Pereira A, Pereira JC, Martins SF. Clinical Impact of Sarcopenia on Gastrointestinal Tumors. Gastrointestinal Disorders. 2021; 3(1):51-60.

Chicago/Turabian Style

Pereira, Ana, Joaquim C. Pereira, and Sandra F. Martins. 2021. "Clinical Impact of Sarcopenia on Gastrointestinal Tumors" Gastrointestinal Disorders 3, no. 1: 51-60.

Find Other Styles

Article Access Map by Country/Region

Back to TopTop